Status:
COMPLETED
Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents
Lead Sponsor:
Glaukos Corporation
Conditions:
Subjects With Primary Open-angle Glaucoma (POAG)
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess efficacy and safety of two iStents for the reduction of intraocular pressure associated with primary open-angle glaucoma.
Detailed Description
This study evaluates the safety and efficacy of two iStents implanted in primary open-angle glaucoma subjects.
Eligibility Criteria
Inclusion
- Diagnosed with primary open-angle glaucoma (POAG)
- Subjects on two topical hypotensive medications
Exclusion
- Traumatic, uveitic, neovascular, or angle closure glaucoma
- Fellow eye already enrolled
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01252888
Start Date
December 1 2010
End Date
December 1 2016
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayna's Ophthalmology Centre
Yerevan, Armenia, 375108